Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Muscle hypertrophy

Not recruiting

Investigational

Study of NT 201 compared to placebo in adults with moderate to severe platysma prominence

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Deucravacitinib

Contact Research Centre

Conjunctivitis allergic+1

Not recruiting

Registered drug

Dose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis

Registered drug

Germany

Participants:18–64 years
Substances:Bilastine

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drugNo placebo

Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Testosterone deficiency syndrome+2

Not recruiting

InvestigationalNo placebo

Relative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms

InvestigationalNo placebo

Germany

Participants:18–64 years · Healthy volunteers
Substances:Elinzanetant

Contact Research Centre

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Not recruiting

Registered drugNo placebo

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Heart failure with reduced ejection fraction

Not recruiting

InvestigationalNo placebo

A study comparing blood levels of finerenone when taken as one 40 mg tablet versus two 20 mg tablets in healthy male participants

InvestigationalNo placebo

Germany

Participants:18–64 years · Healthy volunteers
Substances:Finerenone

Contact Research Centre

Embolism

Not recruiting

Investigational

A study testing the safety and effects of BAY 3018250 given as a single infusion in increasing doses in healthy men compared to placebo

Investigational

Germany

Participants:18–64 years · Healthy volunteers
Substances:Bay 3018250

Contact Research Centre

Actinic keratosis

Not recruiting

Investigational

Study of Tuvatexib Ointment Compared to Placebo for Patients with Actinic Keratosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:TUVATEXIB

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Rocatinlimab

Contact Research Centre

Testosterone deficiency syndrome+1

Not recruiting

Registered drugNo placebo

Study on How Elinzanetant Affects Dabigatran Etexilate in Healthy Volunteers with Vasomotor Symptoms

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Dabigatran Etexilate

Contact Research Centre

Find therapies in clinical trials near you – page 6

109 trials match your criteria

Muscle hypertrophy

Study of NT 201 compared to placebo in adults with moderate to severe platysma prominence

Psoriasis

Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Conjunctivitis allergic+1

Dose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis

Breast cancer+2

Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Testosterone deficiency syndrome+2

Relative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Heart failure with reduced ejection fraction

A study comparing blood levels of finerenone when taken as one 40 mg tablet versus two 20 mg tablets in healthy male participants

Embolism

A study testing the safety and effects of BAY 3018250 given as a single infusion in increasing doses in healthy men compared to placebo

Actinic keratosis

Study of Tuvatexib Ointment Compared to Placebo for Patients with Actinic Keratosis

Triple negative breast cancer

Study of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy

Dermatitis atopic

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Testosterone deficiency syndrome+1

Study on How Elinzanetant Affects Dabigatran Etexilate in Healthy Volunteers with Vasomotor Symptoms

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.